Lucira Health (LHDX) Financials

$0.03

$-0.01 (-19.29%)

As on 05-May-2023 09:30EDT

Market cap

$18 Mln

Revenue (TTM)

$212 Mln

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	212.13	93.06	0.27	--	--	--
Cost of Revenue	251.16	82.83	1.94	--	--	--
Gross Profit	-39.02	10.22	-1.67	--	--	--
Operating Expenses	102.65	74.76	28.11	7.70	6.16	--
Operating Profit (EBIT)	-141.67	-64.54	-31.93	-13.86	-9.82	--
Other Income	0.28	--	--	--	--	--
Profit before Tax	-143.24	-64.81	-37.35	-8.47	-6.54	--
Provision for Tax	0.02	0.02	7.52	0.67	0.18	--
Profit after Tax (Net Income)	-143.26	-64.83	-44.86	-9.14	-6.72	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-143.28	-64.83	-37.35	-8.47	-6.54	--

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	60.89	188.80	-62.31	-25.67	-17.57	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	45.78	1.22	146.15	31.67	16.35	--
Current Liabilities	82.52	50.33	8.86	1.60	5.49	--
Total Liabilities	271.71	240.35	92.70	7.61	4.27	--

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	68.71	34.07	22.47	1.47	1.59	--
Current Assets	120.47	206.28	70.23	6.13	2.69	--
Total Assets	271.71	240.35	92.70	7.61	4.27	--
Total Debt*	48.09	2.83	25.51	1.11	4.26	--
Net Current Assets	37.95	155.95	61.37	4.53	-2.81	--

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-100.88	-32.52	-7.06	-6.47	--
Cash Flow from Investing Activities	--	-15.39	-18.81	-0.08	-0.15	--
Cash from Financing Activities	--	161.70	107.79	11.14	3.78	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-83.74	146.23	48.28	--	--
ROE (%)	-107.91	-102.50	101.99	42.29	--	--
ROA (%)	-54.90	-38.93	-89.45	-153.90	--	--
EBIT Margin (%)	-66.78	-69.36	-11,868.03	--	--	--
Net Margin (%)	-67.44	-69.67	-16,677.70	--	--	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	558.80	344.93	--	--	--	--
EBIT Growth (%)	-90.67	-102.16	-130.37	-41.19	--	--
Net Profit Growth (%)	-93.09	-44.50	-390.79	-36.05	--	--
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.19	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.15	1.70	--	--	--	--
Close Price ($)	1.06	8.61	--	--	--	--
High Price ($)	9.63	37.99	--	--	--	--
Low Price ($)	1.03	4.23	--	--	--	--
Market Cap ($ Cr)	18.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	0.48	0.01	-0.41	-0.04	-0.24	--
Short term debt to equity ratio	0.04	0.01	-0.01	-0.02	-0.21	--
Current Ratio	1.46	4.10	7.93	3.83	0.49	--
Quick Ratio	0.79	3.09	7.38	--	--	--
Interest Coverage	-60.96	-21,513.33	-602.36	-153.98	-51.66	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	9.06	38.08	176.95	--	--	--
Asset Turnover	0.81	0.56	0.01	--	--	--
Receivable days	--	70.47	1,540.43	--	--	--
Inventory Days	--	122.68	915.48	--	--	--
Payable days	--	51.49	428.29	--	--	--
Cash Conversion Cycle	--	141.66	2,027.62	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.